CADM1 overexpression potentially inhibits the migration and invasion of ovarian cancer cells by regulating the upstream regulatory factor C4b-binding protein (C4BPA) and the PI3/Akt/mTOR signaling pathway [32]. Here, C4BPA is linked to ovarian cancer.